BLFS vs CBRE · rev $56.0M vs P/E 43, rev $21.75B
BioLife Solutions Inc (BLFS) versus CBRE Group Inc Class A (CBRE) — a side-by-side from cached financials, not a winner call.
BioLife Solutions Inc (BLFS) is a medical instruments & supplies company listed on US.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Latest reported BLFS revenue for 2026-06-30 was $56.0M. Net income was $46.3M. BLFS currently screens at market cap $1.05B.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
BLFS currently screens at market cap $1.05B. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Not investment advice. Open the BLFS and CBRE stock pages for the full models.
Not investment advice.